š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The purpose of this Phase I/II study is to determine the safety and effecti...
Status
Recruiting
Location
Medical University of South Carolina
Start Date
2022-03-03
Trial ID
NCT05036226
Treatments Being Tested
The host response against the coronavirus 2 (SARS-CoV-2) appears to be medi...
Status
Suspended
Location
Hospital La Milagrosa, GenesisCare
Start Date
2020-04-21
Trial ID
NCT04394182
This phase I trial of the replication-intact PfSPZ Challenge vaccine given ...
Status
Completed
Location
Kaiser Permanente Washington Health Research Institute - Vaccines and Infectious Diseases
Start Date
2016-09-12
Trial ID
NCT02773979
Treatments Being Tested
The PROTECT open-label randomised basket trial will assess the effectivenes...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-09
Trial ID
NCT04389359
Treatments Being Tested
The purpose of this two part study is to test the safety and efficacy of Ta...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-04-24
Trial ID
NCT01376167
This is a double blind, placebo controlled study in approximately 2,000 hea...
Status
Completed
Location
Children's Hospital Colorado/University of Colorado Denver
Start Date
2020-04-22
Trial ID
NCT04334148
Treatments Being Tested
Study Objective: To test if early preemptive hydroxychloroquine therapy ca...
Status
Terminated
Location
University of Minnesota
Start Date
2020-03-25
Trial ID
NCT04421664
Treatments Being Tested
The trial will develop and validate a platform for quantitative assessment ...
Status
Recruiting
Location
Universidade Federal de Minas Gerais
Start Date
2021-09-30
Trial ID
NCT05041907
Treatments Being Tested
To evaluate the efficacy and safety of hydroxychloroquine (600mgBID) combin...
Status
Unknown
Location
Multiple Locations
Start Date
2022-12-15
Trial ID
NCT05647330
Treatments Being Tested
Open-label dose escalation of Ulixertinib combined with fixed dose of hydro...
Status
Completed
Location
Huntsman Cancer Institute
Start Date
2020-03-17
Trial ID
NCT04145297
Treatments Being Tested